The Role of Anemia of Inflammation in the Course of Chronic HBV Infection in Children
Article Sidebar
Main Article Content
Abstract
The article evaluates the features of the course of chronic HBV infection in children with the background of anemia of inflammation. A brief description of the clinical and laboratory manifestations of the disease is given, depending on the course of anemia and inflammation. The data on hepcidin dynamics are analyzed. The stage–by-stage formation of iron metabolism disorders was revealed, in the form of a true deficiency with a breakdown of ferrokinetic markers – an increase in hepcidin and soluble transferin receptors with the background reduced ferritin values characteristic of iron deficiency anemia in the initial stages of the disease and, redistributive iron deficiency - decrease in hepcidin and soluble transferrin receptors with the background increased ferritin values characteristic of iron overload the body is in the late stages of the disease.
Article Details
Copyright (c) 2025 Il’yasovna IF, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
World Health Organization. Global hepatitis report; 2024. Available from: https://www.who.int/publications/b/76480
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2017;67(2):370–398. Available from: https://www.journal-of-hepatology.eu/article/S0168-8278(17)30185-X/fulltext
European Association for the Study of the Liver. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis—2020 update. J Hepatol. 2021;75(3):659–689. Available from: https://www.journal-of-hepatology.eu/article/S0168-8278(21)00398-6/fulltext
Toima S, Saleh A, Madkour M. Role of hepcidin in anemia of chronic hepatitis C patients. J Am Sci. 2010;6(12):145–154. Available from: http://www.americanscience.org
Tsochatzis E, Papatheodoridis GV, Koliaraki V, Hadziyannis E, Kafiri G, Manesis EK, et al. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. J Viral Hepat. 2010;17(11):800–806. Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2893.2009.01244.x
Khadr N, Okasha H, Nouh H, Semary W. Monitoring hepcidin level in chronic hepatitis C virus patients during therapy. Afro-Egypt J Infect Endem Dis. 2014;4(4):184–194. Available from: https://aeji.journals.ekb.eg/article_17201.html
Camaschella C, Nai A, Silvestri L. Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica. 2020;105(2):260–272. Available from: https://www.haematologica.org/article/view/9569
Nemeth E, Ganz T. Hepcidin-ferroportin interaction controls systemic iron homeostasis. Int J Mol Sci. 2021;22(12):6493. Available from: https://www.mdpi.com/1422-0067/22/12/6493
Silva B, Faustino P. An overview of the molecular basis of iron metabolism regulation and the associated pathologies. Biochim Biophys Acta. 2015;1852(7):1347–1359. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0925443915000693
Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011;117(17):4425–4433. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0006497115309994
Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40–50. Available from: https://ashpublications.org/blood/article/133/1/40/263619
Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood. 2016;127(23):2809–2813. Available from: https://ashpublications.org/blood/article/127/23/2809/35135
Lee P, Peng H, Gelbart T, Wang L, Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S A. 2005;102(6):1906–1910. Available from: https://www.pnas.org/doi/10.1073/pnas.0409808102
Nemeth E, Ganz T. Hepcidin and iron-loading anemias. Haematologica. 2006;91(6):727–732. Available from: https://pubmed.ncbi.nlm.nih.gov/16769573/
Schwartz AJ, Das NK, Ramakrishnan SK, Jain C, Jurkovic MT, Wu J, et al. Hepatic hepcidin/intestinal HIF-2alpha axis maintains iron absorption during iron deficiency and overload. J Clin Invest. 2019;129(1):336–348. Available from: https://www.jci.org/articles/view/122359
Silva B, Faustino P. An overview of the molecular basis of iron metabolism regulation and the associated pathologies. Biochim Biophys Acta. 2015;1852(7):1347–1359. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0925443915000693
Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89(3):1052–1057. Available from: https://ashpublications.org/blood/article/89/3/1052/137404
Oustamanolakis P, Koutroubakis IE, Messaritakis I, Niniraki M, Kouroumalis EA. Soluble transferrin receptor-ferritin index in the evaluation of anemia in inflammatory bowel disease: a case-control study. Ann Gastroenterol. 2011;24(2):108–114. Available from: https://pubmed.ncbi.nlm.nih.gov/24713758/
Skikne BS, Punnonen K, Caldron PH, Bennett MT, Rehu M, Gasior GH, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011;86(11):923–927. Available from: https://onlinelibrary.wiley.com/doi/10.1002/ajh.22108